These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24346166)

  • 21. Identifying predictive markers for personalized treatment selection.
    Shen Y; Cai T
    Biometrics; 2016 Dec; 72(4):1017-1025. PubMed ID: 26999054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accounting for interactions and complex inter-subject dependency in estimating treatment effect in cluster-randomized trials with missing outcomes.
    Prague M; Wang R; Stephens A; Tchetgen Tchetgen E; DeGruttola V
    Biometrics; 2016 Dec; 72(4):1066-1077. PubMed ID: 27060877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.
    Clevenbergh P; Boulmé R; Kirstetter M; Dellamonica P
    HIV Med; 2004 Jul; 5(4):284-8. PubMed ID: 15236618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of first-line antiretroviral therapy in Latin America: analysis from the LATINA retrospective cohort study.
    Angriman F; Belloso WH; Sierra-Madero J; Sánchez J; Moreira RI; Kovalevski LO; Orellana LC; Cardoso SW; Crabtree-Ramirez B; La Rosa A; Losso MH
    Int J STD AIDS; 2016 Feb; 27(2):118-26. PubMed ID: 25740759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study on treatment of HIV infected persons based on viral load detection and CD4+ T lymphocyte counting].
    Lin X; Xu L; Feng Y; Li J; Pei L; Shen T; Shao Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):211-4. PubMed ID: 12665921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors for response to a boosted dual HIV-protease inhibitor therapy with saquinavir and lopinavir in extensively pre-treated patients.
    von Hentig N; Babacan E; Staszewski S; Stürmer M; Doerr HW; Lötsch J
    Antivir Ther; 2007; 12(8):1237-46. PubMed ID: 18240863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
    Hogan JW; Lancaster T
    Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral load as a surrogate end point in HIV disease.
    Smith CL; Stein GE
    Ann Pharmacother; 2002 Feb; 36(2):280-7. PubMed ID: 11847950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
    Fagard C; Oxenius A; Günthard H; Garcia F; Le Braz M; Mestre G; Battegay M; Furrer H; Vernazza P; Bernasconi E; Telenti A; Weber R; Leduc D; Yerly S; Price D; Dawson SJ; Klimkait T; Perneger TV; McLean A; Clotet B; Gatell JM; Perrin L; Plana M; Phillips R; Hirschel B;
    Arch Intern Med; 2003 May; 163(10):1220-6. PubMed ID: 12767960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of dolutegravir and efavirenz on immune recovery markers: results from a randomized clinical trial.
    Blanco JR; Alejos B; Moreno S
    Clin Microbiol Infect; 2018 Aug; 24(8):900-907. PubMed ID: 29183782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.
    Castor D; Vlahov D; Hoover DR; Berkman A; Wu YF; Zeller B; Brechtl J; Hammer SM
    J Med Virol; 2009 Aug; 81(8):1323-35. PubMed ID: 19551816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group.
    AIDS; 1999 Apr; 13(5):565-73. PubMed ID: 10203381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple Overimputation.
    Schomaker M; Hogger S; Johnson LF; Hoffmann CJ; Bärnighausen T; Heumann C
    Epidemiology; 2015 Sep; 26(5):628-36. PubMed ID: 26214336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case-only approach to identifying markers predicting treatment effects on the relative risk scale.
    Dai JY; Liang CJ; LeBlanc M; Prentice RL; Janes H
    Biometrics; 2018 Jun; 74(2):753-763. PubMed ID: 28960244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control.
    Assoumou L; Weiss L; Piketty C; Burgard M; Melard A; Girard PM; Rouzioux C; Costagliola D;
    AIDS; 2015 Sep; 29(15):2003-7. PubMed ID: 26355572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
    Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
    Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between virologic and immunologic responses in AIDS clinical research using mixed-effects varying-coefficient models with measurement error.
    Liang H; Wu H; Carroll RJ
    Biostatistics; 2003 Apr; 4(2):297-312. PubMed ID: 12925523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.